Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension

Experimental Physiology

Volumn 100, Issue 6, 2015, Pages 742-754

  Brown, Mary Beth ^a,b   Chingombe, Tsungai J ^a   Zinn, Abigail B ^a   Reddy, Jagadeshwar G ^b   Novack, Rachel A ^a   Cooney, Sean A ^a   Fisher, Amanda J ^b   Presson, Robert G ^b   Lahm, Tim ^b   Petrache, Irina ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE TRANSPORTER 1; MONOCROTALINE; NOS3 PROTEIN, RAT;

AEROBIC CAPACITY; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVATION; EXERCISE; GLYCOLYSIS; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HEART STRESS; HEMODYNAMIC PARAMETERS; INFLAMMATION; JUGULAR VEIN; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; RAT MODEL; RIGHT VENTRICULAR WALL STRESS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE CYTOPLASMIC GLYCOLYSIS; SYSTOLIC BLOOD PRESSURE; TELEMETRY; TREADMILL EXERCISE; VASODILATATION; VENOUS OXYGEN TENSION; ANIMAL; ARTERIAL PRESSURE; BLOOD PRESSURE MONITORING; CARDIAC MUSCLE; CHEMICALLY INDUCED; DISEASE MODEL; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HEMODYNAMICS; HYPERTENSION, PULMONARY; KINESIOTHERAPY; KINETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PULMONARY ARTERY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIAL PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXERCISE THERAPY; GLYCOLYSIS; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; KINETICS; MALE; MONOCROTALINE; MUSCLE, SKELETAL; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; PREDICTIVE VALUE OF TESTS; PULMONARY ARTERY; RATS, SPRAGUE-DAWLEY; TELEMETRY; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 84930584645     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085182     Document Type: Article

References (36)

1. Archer SL, Fang YH, Ryan JJ & Piao L (2013). Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ 3, 144-152.
2. Archer SL, Weir EK & Wilkins MR (2009). Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121, 2045-2066.
3. Bedford TG, Tipton CM, Wilson NC, Oppliger RA & Gisolfi CV (1979). Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol 47, 1278-1283.
4. Bossone E & Naeije R (2012). Exercise-induced pulmonary hypertension. Heart Fail Clin 8, 485-495.
5. de Man FS, Handoko ML, Groepenhoff H, van't Hul AJ, Abbink J, Koppers RJ, Grotjohan HP, Twisk JW, Bogaard HJ, Boonstra A, Postmus PE, Westerhof N, van der Laarse WJ & Vonk-Noordegraaf A (2009). Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 34, 669-675.
6. Fox BD, Kassirer M, Weiss I, Raviv Y, Peled N, Shitrit D & Kramer MR (2011). Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail 17, 196-200.
7. Gielen S, Sandri M, Erbs S & Adams V (2011). Exercise-induced modulation of endothelial nitric oxide production. Curr Pharm Biotechnol 12, 1375-1384.
8. Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R & Nagel C (2012). Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 40, 84-92.
9. Handoko ML, de Man FS, Happé CM, Schalij I, Musters RJ, Westerhof N, Postmus PE, Paulus WJ, van der Laarse WJ & Vonk-Noordegraaf A (2009). Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation 120, 42-49.
10. Handoko ML, Schalij I, Kramer K, Sebkhi A, Postmus PE, van der Laarse WJ, Paulus WJ & Vonk-Noordegraaf A (2008). A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research. Pflugers Arch 455, 951-959.
11. Janicki JS, Weber KT, Likoff MJ & Fishman AP (1985). The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 72, 1270-1278.
12. Johnson LR, Rush JW, Turk JR, Price EM & Laughlin MH (2001). Short-term exercise training increases ACh-induced relaxation and eNOS protein in porcine pulmonary arteries. J Appl Physiol 90, 1102-1110.
13. Kojda G & Hambrecht R (2005). Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67, 187-197.
14. Konduri GG, Ou J, Shi Y & Pritchard KA (2003). Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 285, H204-H211.
15. Kovacs G, Berghold A, Scheidl S & Olschewski H (2009). Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34, 888-894.
16. Kuchan MJ & Frangos JA (1994). Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol Cell Physiol 266, C628-C636.
17. Kuru O, Şentürk UK, Koçer G, Ozdem S, Başkurt OK, Çetin A, Yeşilkaya A & Gündüz F (2009). Effect of exercise training on resistance arteries in rats with chronic NOS inhibition. J Appl Physiol 107, 896-902.
18. Lahm T, Albrecht M, Fisher AJ, Selej M, Patel NG, Brown JA, Justice MJ, Brown MB, Van Demark M, Trulock KM, Dieudonne D, Reddy JG, Presson RG & Petrache I (2012). 17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am J Respir Crit Care Med 185, 965-980.
19. Lewis GD, Bossone E, Naeije R, Grünig E, Saggar R, Lancellotti P, Ghio S, Varga J, Rajagopalan S, Oudiz R & Rubenfire M (2013). Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 128, 1470-1479.
20. Lockett AD, Brown MB, Santos-Falcon N, Rush NI, Oueini H, Oberle AJ, Bolanis E, Fragoso MA, Petrusca DN, Serban KA, Schweitzer KS, Presson RG Jr, Campos M & Petrache I (2014). Active trafficking of alpha 1 antitrypsin across the lung endothelium. PLoS One 9, e93979.
21. Mainguy V, Maltais F, Didier S, Gagnon P, Martel S, Simon M & Provencher S (2010). Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary hypertension. J Cardiopulm Rehabil Prev 30, 319-323.
22. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper M, Halank M, Meyer F, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth F, Wilkens H, Katus H, Olschewski H & Grünig E (2006). Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 114, 1482-1489.
23. Miyauchi T, Maeda S, Iemitsu M, Kobayashi T, Kumagai Y, Yamaguchi I & Matsuda M (2003). Exercise causes a tissue-specific change of NO production in the kidney and lung. J Appl Physiol 94, 60-68.
24. Naeije R, Vanderpool R, Dhakal BP, Saggar R, Saggar R, Vachiery JL & Lewis GD (2013). Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 187, 576-583.
25. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR & Tuder RM (2006). α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169, 1155-1166.
26. Ruiter G, de Man FS, Schalij I, Sairras S, Grunberg K, Westerhof N, van der Laarse WJ & Vonk-Noordegraaf A (2013). Reversibility of the monocrotaline pulmonary hypertension rat model. Eur Respir J 42, 553-556.
27. Sessa WC, Pritchard K, Seyedi N, Wang J & Hintze TH (1994). Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74, 349-353.
28. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W & Hintze TH (1995). Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc 27, 1125-1134.
29. Stenmark KR, Meyrick B, Galie N, Mooi WJ & McMurtry IF (2009). Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol - Lung Cell Mol Physiol 297(6), L1013-L32.
30. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R & Liu PP (2007). Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115, 1398-1407.
31. Thompson WR, ed. (2010). ACSM's Guidelines for Exercise Testing and Prescription. Lippincott Williams and Wilkins, Baltimore.
32. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP & Systrom DM (2008). Exercise-induced pulmonary arterial hypertension. Circulation 118, 2183-2189.
33. Uchi M, Saji T & Harada T (2005). [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy]. J Cardiol 46, 183-193.
34. Whipp BJ, Higgenbotham MB & Cobb FC (1996). Estimating exercise stroke volume from asymptotic oxygen pulse in humans. J Appl Physiol 816, 2674-2679.
35. Zafrir B (2013). Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation. J Cardiopulm Rehabil Prev 33, 263-273.
36. Zhou M, Widmer RJ, Xie W, Widmer AJ, Miller MW, Schroeder F, Parker JL & Heaps CL (2010). Effects of exercise training on cellular mechanisms of endothelial nitric oxide synthase regulation in coronary arteries after chronic occlusion. Am J Physiol Heart Circ Physiol 298, H1857-H1869.